Alkem Laboratories Limited

NSEI:ALKEM Rapport sur les actions

Capitalisation boursière : ₹692.3b

La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Alkem Laboratories Bilan de santé

Santé financière contrôle des critères 6/6

Alkem Laboratories possède un total de capitaux propres de ₹107.1B et une dette totale de ₹14.2B, ce qui porte son ratio d'endettement à 13.2%. Son actif total et son passif total sont ₹155.7B et de ₹48.6B. L'EBIT de Alkem Laboratories est ₹21.8B ce qui fait que son ratio de couverture des intérêts -11.1. Elle dispose de liquidités et de placements à court terme de ₹42.7B.

Informations clés

13.2%

Ratio d'endettement

₹14.18b

Dette

Ratio de couverture des intérêts-11.1x
Argent liquide₹42.70b
Fonds propres₹107.14b
Total du passif₹48.61b
Total des actifs₹155.75b

Mises à jour récentes de la santé financière

Recent updates

Earnings Beat: Alkem Laboratories Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Aug 13
Earnings Beat: Alkem Laboratories Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Alkem Laboratories' (NSE:ALKEM) Shareholders Will Receive A Smaller Dividend Than Last Year

Jul 27
Alkem Laboratories' (NSE:ALKEM) Shareholders Will Receive A Smaller Dividend Than Last Year

Alkem Laboratories' (NSE:ALKEM) Dividend Will Be Reduced To ₹5.00

Jul 13
Alkem Laboratories' (NSE:ALKEM) Dividend Will Be Reduced To ₹5.00

Alkem Laboratories' (NSE:ALKEM) Shareholders Will Receive A Smaller Dividend Than Last Year

Jun 27
Alkem Laboratories' (NSE:ALKEM) Shareholders Will Receive A Smaller Dividend Than Last Year

Alkem Laboratories (NSE:ALKEM) Has Announced That Its Dividend Will Be Reduced To ₹5.00

Jun 13
Alkem Laboratories (NSE:ALKEM) Has Announced That Its Dividend Will Be Reduced To ₹5.00

Alkem Laboratories Limited (NSE:ALKEM) Just Reported Annual Earnings: Have Analysts Changed Their Mind On The Stock?

Jun 01
Alkem Laboratories Limited (NSE:ALKEM) Just Reported Annual Earnings: Have Analysts Changed Their Mind On The Stock?

Earnings Tell The Story For Alkem Laboratories Limited (NSE:ALKEM)

May 22
Earnings Tell The Story For Alkem Laboratories Limited (NSE:ALKEM)

Alkem Laboratories Limited (NSE:ALKEM) Just Reported And Analysts Have Been Lifting Their Price Targets

Feb 13
Alkem Laboratories Limited (NSE:ALKEM) Just Reported And Analysts Have Been Lifting Their Price Targets

Investors Appear Satisfied With Alkem Laboratories Limited's (NSE:ALKEM) Prospects

Jan 17
Investors Appear Satisfied With Alkem Laboratories Limited's (NSE:ALKEM) Prospects

We Think Alkem Laboratories (NSE:ALKEM) Can Manage Its Debt With Ease

Dec 27
We Think Alkem Laboratories (NSE:ALKEM) Can Manage Its Debt With Ease

Is Alkem Laboratories (NSE:ALKEM) Using Too Much Debt?

Sep 14
Is Alkem Laboratories (NSE:ALKEM) Using Too Much Debt?

Alkem Laboratories (NSE:ALKEM) Is Paying Out A Larger Dividend Than Last Year

Aug 02
Alkem Laboratories (NSE:ALKEM) Is Paying Out A Larger Dividend Than Last Year

Alkem Laboratories (NSE:ALKEM) Is Paying Out A Larger Dividend Than Last Year

Jul 07
Alkem Laboratories (NSE:ALKEM) Is Paying Out A Larger Dividend Than Last Year

Alkem Laboratories (NSE:ALKEM) Is Paying Out A Larger Dividend Than Last Year

May 22
Alkem Laboratories (NSE:ALKEM) Is Paying Out A Larger Dividend Than Last Year

We Think Alkem Laboratories (NSE:ALKEM) Can Stay On Top Of Its Debt

Mar 27
We Think Alkem Laboratories (NSE:ALKEM) Can Stay On Top Of Its Debt

Does Alkem Laboratories (NSE:ALKEM) Have A Healthy Balance Sheet?

Dec 26
Does Alkem Laboratories (NSE:ALKEM) Have A Healthy Balance Sheet?

These 4 Measures Indicate That Alkem Laboratories (NSE:ALKEM) Is Using Debt Reasonably Well

Sep 20
These 4 Measures Indicate That Alkem Laboratories (NSE:ALKEM) Is Using Debt Reasonably Well

Alkem Laboratories' (NSE:ALKEM) Dividend Is Being Reduced To ₹4.00

Jul 27
Alkem Laboratories' (NSE:ALKEM) Dividend Is Being Reduced To ₹4.00

Alkem Laboratories' (NSE:ALKEM) Shareholders Will Receive A Smaller Dividend Than Last Year

Jul 13
Alkem Laboratories' (NSE:ALKEM) Shareholders Will Receive A Smaller Dividend Than Last Year

Does This Valuation Of Alkem Laboratories Limited (NSE:ALKEM) Imply Investors Are Overpaying?

Jun 11
Does This Valuation Of Alkem Laboratories Limited (NSE:ALKEM) Imply Investors Are Overpaying?

Does Alkem Laboratories (NSE:ALKEM) Have A Healthy Balance Sheet?

May 23
Does Alkem Laboratories (NSE:ALKEM) Have A Healthy Balance Sheet?

Does This Valuation Of Alkem Laboratories Limited (NSE:ALKEM) Imply Investors Are Overpaying?

Mar 06
Does This Valuation Of Alkem Laboratories Limited (NSE:ALKEM) Imply Investors Are Overpaying?

Does Alkem Laboratories (NSE:ALKEM) Have A Healthy Balance Sheet?

Feb 21
Does Alkem Laboratories (NSE:ALKEM) Have A Healthy Balance Sheet?

Alkem Laboratories (NSE:ALKEM) Is Paying Out A Larger Dividend Than Last Year

Feb 08
Alkem Laboratories (NSE:ALKEM) Is Paying Out A Larger Dividend Than Last Year

Should You Be Adding Alkem Laboratories (NSE:ALKEM) To Your Watchlist Today?

Jan 09
Should You Be Adding Alkem Laboratories (NSE:ALKEM) To Your Watchlist Today?

Does This Valuation Of Alkem Laboratories Limited (NSE:ALKEM) Imply Investors Are Overpaying?

Nov 30
Does This Valuation Of Alkem Laboratories Limited (NSE:ALKEM) Imply Investors Are Overpaying?

Here's Why Alkem Laboratories (NSE:ALKEM) Can Manage Its Debt Responsibly

Nov 17
Here's Why Alkem Laboratories (NSE:ALKEM) Can Manage Its Debt Responsibly

I Built A List Of Growing Companies And Alkem Laboratories (NSE:ALKEM) Made The Cut

Sep 07
I Built A List Of Growing Companies And Alkem Laboratories (NSE:ALKEM) Made The Cut

Analyse de la situation financière

Passif à court terme: Les actifs à court terme de ALKEM ( ₹104.1B ) dépassent ses passifs à court terme ( ₹39.9B ).

Passif à long terme: Les actifs à court terme de ALKEM ( ₹104.1B ) dépassent ses passifs à long terme ( ₹8.7B ).


Historique et analyse du ratio d'endettement

Niveau d'endettement: ALKEM dispose de plus de liquidités que de sa dette totale.

Réduire la dette: Le ratio d'endettement de ALKEM a été réduit de 16.9% à 13.2% au cours des 5 dernières années.

Couverture de la dette: La dette de ALKEM est bien couverte par le flux de trésorerie opérationnel ( 137.3% ).

Couverture des intérêts: ALKEM gagne plus d'intérêts qu'il n'en paie, donc la couverture des paiements d'intérêts n'est pas un problème.


Bilan


Découvrir des entreprises saines